In a pivotal move that could reshape the federal stance on marijuana, a top official at the Department of Health and Human Services (HHS) has recommended that the substance be reclassified as a Schedule III substance under the Controlled Substances Act. The recommendation was directed to Drug Enforcement Agency (DEA) administrator Anne Milgram in a letter dated Aug. 29, according to documentation obtained by Bloomberg News.
Benzinga spoke to cannabis industry insiders to get further insights. More from Kim Rivers, CEO at Trulieve Cannabis Corp (OTC:TCNNF); George Archos, CEO at Verano Holdings Corp (OTC:VRNOF), Cory Gardner, NCR Advisory Member; Charlie Bachtell, CEO and co-founder of Cresco Labs (OTC:CRLBF); and Boris Jordan, founder and chairman of Curaleaf Holdings (OTC:CURLF), below.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.